Viral Hepatitis

	Viral hepatitis: chairman's introduction J-P Benhamou Gut 1993; 34 (2 Suppl): IV. doi:10.1136/gut.34.2_Suppl.IV [PDF] [Request Permissions]

Research Article

	Virological and serological aspects of hepatitis B and the delta agent. G Hess Gut 1993; 34 (2 Suppl): S1-S5. doi:10.1136/gut.34.2_Suppl.S1 [Abstract] [PDF] [Request Permissions]
	Hepatitis C: looking at a virus that hasn't been seen. L R Overby Gut 1993; 34 (2 Suppl): S6-S9. doi:10.1136/gut.34.2_Suppl.S6 [Abstract] [PDF] [Request Permissions]
	Progress on the control of hepatitis B infection through immunisation. M A Kane Gut 1993; 34 (2 Suppl): S10-S12. doi:10.1136/gut.34.2_Suppl.S10 [Abstract] [PDF] [Request Permissions]
	Epidemiology and long term prognosis of hepatitis C virus infection in Japan. M Yano, H Yatsuhashi, O Inoue, K Inokuchi, and M Koga Gut 1993; 34 (2 Suppl): S13-S16. doi:10.1136/gut.34.2_Suppl.S13 [Abstract] [PDF] [Request Permissions]
	Community acquired viral hepatitis B and C in the United States. M J Alter Gut 1993; 34 (2 Suppl): S17-S19. doi:10.1136/gut.34.2_Suppl.S17 [Abstract] [PDF] [Request Permissions]
	Diagnostic markers of viral hepatitis B and C. C Trépo, F Zoulim, C Alonso, M A Petit, C Pichoud, and L Vitvitski Gut 1993; 34 (2 Suppl): S20-S25. doi:10.1136/gut.34.2_Suppl.S20 [Abstract] [PDF] [Request Permissions]
	Viral markers in the treatment of hepatitis B and C. H Schmilovitz-Weiss, M Levy, N Thompson, and G Dusheiko Gut 1993; 34 (2 Suppl): S26-S35. doi:10.1136/gut.34.2_Suppl.S26 [Abstract] [PDF] [Request Permissions]
	Problems in diagnosing viral hepatitis. F Bonino, G Colloredo Mels, G Bellati, G Ideo, F Oliveri, P Colombatto, and M R Brunetto Gut 1993; 34 (2 Suppl): S36-S38. doi:10.1136/gut.34.2_Suppl.S36 [Abstract] [PDF] [Request Permissions]
	Polymerase chain reaction for the diagnosis of viral hepatitis B and C. C Bréchot Gut 1993; 34 (2 Suppl): S39-S44. doi:10.1136/gut.34.2_Suppl.S39 [Abstract] [PDF] [Request Permissions]
	Role of screening in prevention and treatment. M Kane, M Alter, R Esteban, and M Rizzetto Gut 1993; 34 (2 Suppl): S45-S47. doi:10.1136/gut.34.2_Suppl.S45 [Abstract] [PDF] [Request Permissions]
	Hepatitis B: transmission and natural history. R P Perrillo Gut 1993; 34 (2 Suppl): S48-S49. doi:10.1136/gut.34.2_Suppl.S48 [Abstract] [PDF] [Request Permissions]
	Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France. S Ranger, P Martin, M C Roussanne, and F Denis Gut 1993; 34 (2 Suppl): S50-S51. doi:10.1136/gut.34.2_Suppl.S50 [Abstract] [PDF] [Request Permissions]
	Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis. T Kuroki, S Nishiguchi, K Fukuda, N Ikeoka, R Murata, G Isshiki, S Tomoda, S Ogita, T Monna, and K Kobayashi Gut 1993; 34 (2 Suppl): S52-S53. doi:10.1136/gut.34.2_Suppl.S52 [Abstract] [PDF] [Request Permissions]
	Hepatitis C virus antibody positive blood donors. D Mutimer, J Shaw, R Harrison, F Ala, J Neuberger, and E Elias Gut 1993; 34 (2 Suppl): S54. doi:10.1136/gut.34.2_Suppl.S54 [Abstract] [PDF] [Request Permissions]
	Anti-HCV seroprevalence in pregnant women in France. F Roudot-Thoraval, J M Pawlotsky, L Deforges, P P Girollet, and D Dhumeaux Gut 1993; 34 (2 Suppl): S55-S56. doi:10.1136/gut.34.2_Suppl.S55 [Abstract] [PDF] [Request Permissions]
	Hepatitis C virus infection among Greek renal transplant patients. I Vafiadis, J Boletis, H Papastathi, J Delladetsima, C Stathakis, A Hatzakis, A Kostakis, and G Vosnides Gut 1993; 34 (2 Suppl): S57-S58. doi:10.1136/gut.34.2_Suppl.S57 [Abstract] [PDF] [Request Permissions]
	Detection of HCV-RNA in saliva of patients with chronic hepatitis C. P Couzigou, L Richard, F Dumas, L Schouler, and H Fleury Gut 1993; 34 (2 Suppl): S59-S60. doi:10.1136/gut.34.2_Suppl.S59 [Abstract] [PDF] [Request Permissions]
	Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results. G Baskin, R DiNello, A Polito, S Quan, W S Lee, J Wu, M Nelles, and S Lee Gut 1993; 34 (2 Suppl): S61. doi:10.1136/gut.34.2_Suppl.S61 [Abstract] [PDF] [Request Permissions]
	Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. J Genesca, J I Esteban, J Quer, L L Viladomiu, A Gonzalez, R Esteban, and J Guardia Gut 1993; 34 (2 Suppl): S62-S63. doi:10.1136/gut.34.2_Suppl.S62 [Abstract] [PDF] [Request Permissions]
	Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease. O Yokosuka, M Omata, Y Ito, and M Ohto Gut 1993; 34 (2 Suppl): S64-S65. doi:10.1136/gut.34.2_Suppl.S64 [Abstract] [PDF] [Request Permissions]
	Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. J M Pawlotsky, L Deforges, S Bretagne, C André, J M Métreau, V Thiers, E S Zafrani, M Goossens, J Duval, and J P Mavier Gut 1993; 34 (2 Suppl): S66-S68. doi:10.1136/gut.34.2_Suppl.S66 [Abstract] [PDF] [Request Permissions]
	Historical treatment of chronic hepatitis B and chronic hepatitis C. P Ferenci Gut 1993; 34 (2 Suppl): S69-S73. doi:10.1136/gut.34.2_Suppl.S69 [Abstract] [PDF] [Request Permissions]
	Biological basis for the clinical use of interferon. F Dianzani Gut 1993; 34 (2 Suppl): S74-S76. doi:10.1136/gut.34.2_Suppl.S74 [Abstract] [PDF] [Request Permissions]
	Is there a role for interferon in acute viral hepatitis? R Esteban Gut 1993; 34 (2 Suppl): S77-S80. doi:10.1136/gut.34.2_Suppl.S77 [Abstract] [PDF] [Request Permissions]
	Viral hepatitis management. Standards for the future. Case studies. S Sherlock, S Hadziyannis, M Nishioka, R P Perrillo, E R Schiff, and C Trépo Gut 1993; 34 (2 Suppl): S81-S86. doi:10.1136/gut.34.2_Suppl.S81 [Abstract] [PDF] [Request Permissions]
	Interferon alfa-2b therapy in children with chronic hepatitis B. E M Sokal, S Wirth, P Goyens, A Depreterre, and C Cornu Gut 1993; 34 (2 Suppl): S87-S90. doi:10.1136/gut.34.2_Suppl.S87 [Abstract] [PDF] [Request Permissions]
	A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up. V Perez, J Findor, H Tanno, and J Sordá Gut 1993; 34 (2 Suppl): S91-S94. doi:10.1136/gut.34.2_Suppl.S91 [Abstract] [PDF] [Request Permissions]
	Interferon for hepatitis B: US experience. R P Perrillo Gut 1993; 34 (2 Suppl): S95-S96. doi:10.1136/gut.34.2_Suppl.S95 [Abstract] [PDF] [Request Permissions]
	Low dose alpha interferon treatment in chronic hepatitis B virus infection. R Müller, R Baumgarten, R Markus, M Schulz, H Wittenberg, B Hintsche-Kilger, J D Fengler, P von Wussow, H Meisel, and H Klein Gut 1993; 34 (2 Suppl): S97-S98. doi:10.1136/gut.34.2_Suppl.S97 [Abstract] [PDF] [Request Permissions]
	Low dose interferon alfa-2b for chronic hepatitis B in Asian countries. E Mauracher Gut 1993; 34 (2 Suppl): S99-100. doi:10.1136/gut.34.2_Suppl.S99 [Abstract] [PDF] [Request Permissions]
	Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results. Y Bayraktar, B Uzunalimoglu, S Arslan, T Koseoglu, B Kayhan, and H Telatar Gut 1993; 34 (2 Suppl): S101. doi:10.1136/gut.34.2_Suppl.S101 [Abstract] [PDF] [Request Permissions]
	Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen. M Raptopoulou, H Orphanou, H Vrettou, E Akribiadis, L Chadzikonstantinou, and G Goulis Gut 1993; 34 (2 Suppl): S102-S103. doi:10.1136/gut.34.2_Suppl.S102 [Abstract] [PDF] [Request Permissions]
	Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: preliminary results of a pilot study. M Dimopoulou, K Fafoutis, K Basiliou, J Ketikoglou, and G Karvountzis Gut 1993; 34 (2 Suppl): S104-S105. doi:10.1136/gut.34.2_Suppl.S104 [Abstract] [PDF] [Request Permissions]
	Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine. P Marcellin, N Boyer, J F Colin, M Martinot-Peignoux, V Lefort, S Matheron, S Erlinger, and J P Benhamou Gut 1993; 34 (2 Suppl): S106. doi:10.1136/gut.34.2_Suppl.S106 [Abstract] [PDF] [Request Permissions]
	Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis. G Visco, L Alba, S Grisetti, P Guarascio, P Narciso, P Sette, C Struglia, G Tossini, and V Tozzi Gut 1993; 34 (2 Suppl): S107-S108. doi:10.1136/gut.34.2_Suppl.S107 [Abstract] [PDF] [Request Permissions]
	Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience. G L Davis Gut 1993; 34 (2 Suppl): S109-S111. doi:10.1136/gut.34.2_Suppl.S109 [Abstract] [PDF] [Request Permissions]
	Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment. J M Métreau Gut 1993; 34 (2 Suppl): S112-S113. doi:10.1136/gut.34.2_Suppl.S112 [Abstract] [PDF] [Request Permissions]
	High dose interferon treatment in chronic hepatitis C. S Iino Gut 1993; 34 (2 Suppl): S114-S118. doi:10.1136/gut.34.2_Suppl.S114 [Abstract] [PDF] [Request Permissions]
	Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis). Benelux Multicentre Trial Study Group. Gut 1993; 34 (2 Suppl): S119-S120. doi:10.1136/gut.34.2_Suppl.S119 [Abstract] [PDF] [Request Permissions]
	Interferon alfa for chronic hepatitis C in haemophiliacs. M Makris, F E Preston, D R Triger, J C Underwood, L Westlake, and M I Adelman Gut 1993; 34 (2 Suppl): S121-S123. doi:10.1136/gut.34.2_Suppl.S121 [Abstract] [PDF] [Request Permissions]
	Long term treatment of chronic hepatitis C with interferon alfa-2b: disappearance of HCV-RNA in a pilot study of eight haemophilia patients. D Bresters, E P Mauser-Bunschoten, H T Cuypers, J H Han, P L Jansen, R A Chamuleau, M Houghton, and H W Reesink Gut 1993; 34 (2 Suppl): S124-S125. doi:10.1136/gut.34.2_Suppl.S124 [Abstract] [PDF] [Request Permissions]
	Recombinant interferon alfa-2b treatment in chronic non-A, non-B/type C hepatitis. V De Conca, S Mesiti, E Vallarino, A Mornese, and M Dodero Gut 1993; 34 (2 Suppl): S126. doi:10.1136/gut.34.2_Suppl.S126 [Abstract] [PDF] [Request Permissions]
	Clinical and histological evaluation of interferon alfa-2b in the treatment of chronic hepatitis C. C Panella, A Francavilla, D Conte, I Tatulli, and F Rubini Gut 1993; 34 (2 Suppl): S127. doi:10.1136/gut.34.2_Suppl.S127 [Abstract] [PDF] [Request Permissions]
	Treatment of chronic hepatitis C with recombinant interferon alfa-2b. M Piazza, R Orlando, G Tosone, D Tiseo, M C Conte, F Minervini, G Santoro, F Scordino, and D Vitale Gut 1993; 34 (2 Suppl): S128-S129. doi:10.1136/gut.34.2_Suppl.S128 [Abstract] [PDF] [Request Permissions]
	Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. N C Tassopoulos, M G Koutelou, G Papatheodoridis, H Polychronaki, I Delladetsima, T Giannikakis, A Todoulos, A Toliopoulos, and A Hatzakis Gut 1993; 34 (2 Suppl): S130-S132. doi:10.1136/gut.34.2_Suppl.S130 [Abstract] [PDF] [Request Permissions]
	Quantitative hepatitis C virus RNA and liver histology in chronic hepatitis C patients treated with interferon alfa. G Yamada, M Takahashi, H Endo, T Doi, R Miyamoto, H Shimomura, K Yamamoto, and T Tsuji Gut 1993; 34 (2 Suppl): S133-S134. doi:10.1136/gut.34.2_Suppl.S133 [Abstract] [PDF] [Request Permissions]
	Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C. C De Bac, F Grimaldi, C Clementi, F Duca, D Livoli, and G Taliani Gut 1993; 34 (2 Suppl): S135. doi:10.1136/gut.34.2_Suppl.S135 [Abstract] [PDF] [Request Permissions]
	Treatment of chronic hepatitis C with recombinant interferon alfa-2b for nine months. R Pérez, R Pravia, A Linares, M González, M Rodríguez, J L Lombraña, S Riestra, A Suárez, and L Rodrigo Gut 1993; 34 (2 Suppl): S136-S138. doi:10.1136/gut.34.2_Suppl.S136 [Abstract] [PDF] [Request Permissions]
	Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C. R Pérez, R Pravia, A Linares, M Rodríguez, J L Lombraña, A Suárez, S Riestra, C A Navascués, and L Rodrigo Gut 1993; 34 (2 Suppl): S139-S140. doi:10.1136/gut.34.2_Suppl.S139 [Abstract] [PDF] [Request Permissions]
	Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion. M Colombo, P Lampertico, and M Rumi Gut 1993; 34 (2 Suppl): S141. doi:10.1136/gut.34.2_Suppl.S141 [Abstract] [PDF] [Request Permissions]
	Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia. V Di Marco, O Lo Iacono, M Capra, S Grutta, C Ciaccio, C Gerardi, A Maggio, D Renda, P Almasio, and R Pisa Gut 1993; 34 (2 Suppl): S142-S143. doi:10.1136/gut.34.2_Suppl.S142 [Abstract] [PDF] [Request Permissions]
	Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial. C Ferri, E Marzo, G Longombardo, L La Civita, F Lombardini, D Giuggioli, R Vanacore, A M Liberati, A Mazzoni, and F Greco Gut 1993; 34 (2 Suppl): S144-S145. doi:10.1136/gut.34.2_Suppl.S144 [Abstract] [PDF] [Request Permissions]
	Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon. P Bedossa, T Poynard, P Mathurin, G Lemaigre, and J C Chaput Gut 1993; 34 (2 Suppl): S146-S147. doi:10.1136/gut.34.2_Suppl.S146 [Abstract] [PDF] [Request Permissions]
	Treatment algorithms for hepatitis B and C. E R Schiff Gut 1993; 34 (2 Suppl): S148-S149. doi:10.1136/gut.34.2_Suppl.S148 [Abstract] [PDF] [Request Permissions]